ArticleHarm reduction journal2025
From trash to results: shortcomings and benefits of paraphernalia-based drug checking in Finland.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDrug checking is a harm reduction intervention that combines the identification of the chemical content of a drug with an information-sharing intervention concerning the risks of drug use. Despite growing evidence of the usefulness of this method, legal obstacles in many countries constrain the implementation of drug checking. The purpose of this Finnish study was to evaluate the usefulness of a paraphernalia-based drug-checking protocol.
methodsA total of 503 drug paraphernalia samples were submitted between April 2022 and July 2024 to 9 different harm reduction services. The samples were analysed monthly via chromatography‒mass spectrometry, and the visitors had the option to return to discuss the results after laboratory analysis. The questionnaire data were collected both during sample submission and the discussion of the results. Additionally, six thematic paired interviews were conducted with staff who performed drug checking at different service locations.
resultsThe concordance between the promised and detected contents varied greatly depending on the submitted substance. Over two-thirds of the samples were submitted by visitors who had never used substance use services before. The visitors returned for the laboratory results for only 208 samples. The interviewed staff believed that a long waiting time was the main reason for the low return rate. The staff also identified several advantages. The sample submission as well as the dissemination of the recent results via posters at the service points offered an easy way to approach people and discuss different topics related to drug use, harm reduction, and social and health issues.
conclusionThe protocol used was too slow for visitors to make preconsumption decisions. However, this shortcoming was not directly connected to the use of paraphernalia samples instead of actual drug samples, as the protocol could be accelerated with sufficient resources. The use of paraphernalia also caused uncertainties related to presubmission contamination. However, the protocol proved to be beneficial for initiating harm reduction discussions during the submission of the samples and the public dissemination of the results at the service locations, and should be considered as a starting point for drug checking when the use of actual drug samples is not possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.